on the basis of epidemiologic and experimental evidence of an anticancer activity of vitamin a , a randomized clinical trial was activated in milan with the aim of evaluating if retinol palmitate administration ( per os , 300,000 i.u . daily ) after complete resection of stage ia non small-cell lung cancer could reduce the occurrence of cancer relapses ( within 3 years ) and/or the occurrence of new primary tumors ( beyond 3 years ) .
C0042839
vitamin a
C0073115
retinol palmitate